• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1994 - 1995年古巴的癌症生存率

Cancer survival in Cuba, 1994-1995.

作者信息

Garrote L F, Alvarez Y G, Babie P T, Yi M G, Alvarez M G, Cicili M L

机构信息

Registro Nacional de Cancer de Cuba, Instituto Nacional Oncologia y Radiobiologia, La Habana, Cuba.

出版信息

IARC Sci Publ. 2011(162):89-95.

PMID:21675409
Abstract

The population-based cancer registry in Cuba is a national cancer registry established in 1964; cancer registration is entirely done by passive methods. Data on survival from 13 cancer sites or types registered during 1994-1995 are reported. Follow-up has been carried out predominantly by passive methods, with median follow-up ranging from 13-54 months. The proportion with histologically verified diagnosis for various cancers ranged between 34-100%; death certificates only (DCOs) comprised 8-50%; 50-89% of total registered cases were included for the survival analysis. The 5-year age-standardized relative survival for selected cancers were breast (69%), colon (41%), cervix (56%), urinary bladder (64%), rectum (48%) and non-Hodgkin lymphoma (49%). The 5-year relative survival by age group showed no distinct pattern or trend, and was fluctuating. A decreasing survival with increasing clinical extent of disease was noted for all cancers studied. The data on survival trend revealed that the 5-year relative survival of most cancers diagnosed in 1994-1995 was greater than that in 1988-1989.

摘要

古巴基于人群的癌症登记处是1964年建立的国家癌症登记处;癌症登记完全通过被动方法完成。报告了1994 - 1995年期间登记的13个癌症部位或类型的生存数据。随访主要通过被动方法进行,中位随访时间为13 - 54个月。各种癌症经组织学证实诊断的比例在34% - 100%之间;仅死亡证明(DCOs)占8% - 50%;纳入生存分析的病例占登记病例总数的50% - 89%。选定癌症的5年年龄标准化相对生存率分别为乳腺癌(69%)、结肠癌(41%)、子宫颈癌(56%)、膀胱癌(64%)、直肠癌(48%)和非霍奇金淋巴瘤(49%)。按年龄组划分的5年相对生存率没有明显的模式或趋势,且呈波动状态。在所研究的所有癌症中,均发现随着疾病临床分期增加生存率下降。生存趋势数据显示,1994 - 1995年诊断的大多数癌症的5年相对生存率高于1988 - 1989年。

相似文献

1
Cancer survival in Cuba, 1994-1995.1994 - 1995年古巴的癌症生存率
IARC Sci Publ. 2011(162):89-95.
2
Cancer survival in Seoul, Republic of Korea, 1993-1997.1993 - 1997年韩国首尔的癌症生存率
IARC Sci Publ. 2011(162):171-8.
3
Cancer survival in Izmir, Turkey, 1995-1997.1995 - 1997年土耳其伊兹密尔的癌症生存率
IARC Sci Publ. 2011(162):237-42.
4
Cancer survival in Incheon, Republic of Korea, 1997-2001.1997 - 2001年韩国仁川的癌症生存率
IARC Sci Publ. 2011(162):163-9.
5
Cancer survival in Singapore, 1993-1997.1993 - 1997年新加坡的癌症生存率
IARC Sci Publ. 2011(162):183-98.
6
Cancer survival in Mumbai (Bombay), India, 1992-1999.1992 - 1999年印度孟买(旧称: Bombay)的癌症生存率。
IARC Sci Publ. 2011(162):133-42.
7
Cancer survival in Busan, Republic of Korea, 1996-2001.1996 - 2001年韩国釜山的癌症生存率
IARC Sci Publ. 2011(162):155-62.
8
Cancer survival in Barshi, India, 1993-2000.印度巴尔希1993 - 2000年癌症生存率
IARC Sci Publ. 2011(162):101-6.
9
Cancer survival in Khon Kaen, Thailand, 1993-1997.1993 - 1997年泰国孔敬府的癌症生存率
IARC Sci Publ. 2011(162):211-6.
10
Cancer survival in Bhopal, India, 1991-1995.1991 - 1995年印度博帕尔的癌症生存率
IARC Sci Publ. 2011(162):107-13.

引用本文的文献

1
Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis.拉丁美洲和加勒比地区乳腺癌的诊断分期和特定分期的生存情况:系统评价和荟萃分析。
PLoS One. 2019 Oct 16;14(10):e0224012. doi: 10.1371/journal.pone.0224012. eCollection 2019.
2
Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis.伊朗结直肠癌的生存率:系统评价与荟萃分析
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):13-21. doi: 10.31557/APJCP.2019.20.1.13.
3
Breast Cancer Research in the Caribbean: Analysis of Reports From 1975 to 2017.
加勒比地区的乳腺癌研究:1975年至2017年报告分析
J Glob Oncol. 2018 Nov;4:1-21. doi: 10.1200/JGO.18.00044.